ProCE Banner Activity

Current and Emerging Roles of BTK Inhibitors in Treatment-Naive MCL

Slideset

Download these slides from a live symposium at ASH 2023 to learn more about the current and emerging roles of BTK inhibitors in previously untreated MCL.

Released: December 06, 2023

Share

Faculty

Matthew Lunning

Matthew Lunning, DO, FACP

Associate Professor
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca